SIGNet’s functions are to:

  • Link network Executive Officers
  • Facilitate information sharing and mentoring of new Executive Officers
  • Provide an opportunity to share insights on activities done well and to identify solutions to problems
  • Provide updates from the sector and to receive updates from ACTA.

SIGNet is ACTA’s Special Interest Group for Network Managers. Each Clinical Trial Network may nominate a representative on SIGNet.

SIGNet provides a forum for Executive Officers, Network Managers and CTN representatives (generally referred to as Executive Officers), to share knowledge and expertise, identify issues, exchange information and engage in collaborative problem solving.

Group Leadership

  • Ms Julia Fallon-Ferguson
  • Ms Marilena Salvo

Project Officer

Ms Julie Armstrong

Latest Resources

Latest News